B2M and prostate cancer: In this study we demonstrate that inhibition of β2-M using an antibody or genetic deletion of β2-M or HFE in cancer cells causes iron overload and sensitizes prostate cancer cells to radiation in vitro and in vivo and chemotherapeutic agents in vitro.